Anil Chandraker
Overview
Explore the profile of Anil Chandraker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
122
Citations
2853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Isakov O, Patibandla B, Christopher K, Chandraker A, Hod T
Kidney Blood Press Res
. 2022 Feb;
47(5):341-353.
PMID: 35196662
Background: Post-transplant hypomagnesemia is commonly observed among patients prescribed calcineurin inhibitor (CNIs). Methods: We conducted a retrospective single-center analysis (2000-2013, N = 726) to examine the association of hypomagnesemia with...
12.
Watts A, Keller K, Lerner G, Rosales I, Collins A, Sekulic M, et al.
J Am Soc Nephrol
. 2021 Nov;
33(1):238-252.
PMID: 34732507
Background: Failure of the glomerular filtration barrier, primarily by loss of slit diaphragm architecture, underlies nephrotic syndrome in minimal change disease. The etiology remains unknown. The efficacy of B cell-targeted...
13.
Garg N, Mandelbrot D, Parajuli S, Aziz F, Astor B, Chandraker A, et al.
Transplant Rev (Orlando)
. 2021 Sep;
35(4):100649.
PMID: 34507254
Early diagnosis is critical to minimizing the damage rejection can do to the transplanted kidney. Donor-derived cell-free DNA (dd-cfDNA) represents non-encapsulated fragmented DNA that is continuously shed into the bloodstream...
14.
Courtwright A, Patel N, Chandraker A, Goldberg H
Am J Transplant
. 2021 Aug;
22(3):698-704.
PMID: 34379882
Women with advanced lung disease, particularly Black and Hispanic women, are more likely than other patients to have anti-human leukocyte (HLA) antibodies against potential donors. Sensitized patients, especially those who...
15.
Martin-Moreno P, Shin H, Chandraker A
J Clin Med
. 2021 Jul;
10(11).
PMID: 34198724
Worldwide, the prevalence obesity, diabetes, and chronic kidney disease is increasing apace. The relationship between obesity and chronic kidney disease is multidimensional, especially when diabetes is also considered. The optimal...
16.
Kauke M, Panayi A, Safi A, Haug V, Perry B, Kollar B, et al.
Am J Transplant
. 2021 May;
21(10):3472-3480.
PMID: 34033210
There is limited experience with facial retransplantation (fRT). We report on the management of facial retransplantation in a facial vascularized composite allotransplant recipient following irreversible allograft loss 88 months after...
17.
Zhang H, Wang Z, Zhang J, Gui Z, Han Z, Tao J, et al.
Front Immunol
. 2021 Mar;
12:618737.
PMID: 33732243
Background: Costimulatory blockade provides new therapeutic opportunities for ensuring the long-term survival of kidney grafts. The adoption of the novel immunosuppressant Belatacept has been limited, partly due to concerns regarding...
18.
Win T, Crisler W, Dyring-Andersen B, Lopdrup R, Teague J, Zhan Q, et al.
J Clin Invest
. 2021 Mar;
131(8).
PMID: 33667197
BACKGROUNDRejection is the primary barrier to broader implementation of vascularized composite allografts (VCAs), including face and limb transplants. The immunologic pathways activated in face transplant rejection have not been fully...
19.
El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C, et al.
J Am Soc Nephrol
. 2021 Mar;
32(4):994-1004.
PMID: 33658284
Background: Developing a noninvasive clinical test to accurately diagnose kidney allograft rejection is critical to improve allograft outcomes. Urinary exosomes, tiny vesicles released into the urine that carry parent cells'...
20.
Mohammed M, Cai S, Hanson B, Zhang H, Clement R, Daccache J, et al.
Am J Transplant
. 2021 Jan;
21(5):1893-1901.
PMID: 33421294
Following solid organ transplantation, a substantial proportion of chronic allograft loss is attributed to the formation of donor-specific antibodies (DSAs) and antibody-mediated rejection (AbMR). The frequency and phenotype of T...